SCHEMBL1632835

SCHEMBL1632835

C[Ge](C)(C(=O)c1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.55
▸ TSHR P16473 3/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ PARP1 P09874 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ PMP22 Q01453 1/20 0.55
▸ CES1 P23141 8/20 0.52
▸ CES2 O00748 7/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ DAO P14920 1/20 0.52
▸ NAPRT Q6XQN6 1/20 0.52
▸ CA2 P00918 2/20 0.48
▸ CA4 P22748 2/20 0.48
▸ CA12 O43570 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL272138 0.83 TDP1 (0.55) TDP1TSHRCYP3A4MAPTHSD17B10
SCHEMBL18687120 0.80 TDP1 (0.57) TDP1TSHRCYP3A4MAPTHSD17B10
SCHEMBL30863826 0.78 TDP1 (0.55) TDP1TSHRCYP3A4MAPTHSD17B10
SCHEMBL21879778 0.76 ALDH1A1 (0.59) TDP1MAPTCES1CES2ALDH1A1
SCHEMBL4019209 0.75 CES1 (0.48) TDP1TSHRCYP3A4MAPTHSD17B10
SCHEMBL22204644 0.75 CES1 (0.48) TDP1TSHRCYP3A4MAPTHSD17B10
SCHEMBL274249 0.75 CES1 (0.48) TDP1TSHRCYP3A4MAPTHSD17B10
Benzamide SCHEMBL28132124 0.72 PARP1 (0.89) TDP1TSHRCYP3A4MAPTHSD17B10
Benzamide SCHEMBL27340650 0.72 PARP1 (0.89) TDP1TSHRCYP3A4MAPTHSD17B10
Benzamide SCHEMBL2061911 0.72 PARP1 (0.89) TDP1TSHRCYP3A4MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119377-B1 PHOTOPOLYMERISABLE AND DUAL HARDENING DENTAL MATERIAL BASED ON THIOUREA DERIVATIVES AND BISACYLDIALKYLGERMANIUM-COMPOUNDS IVOCLAR VIVADENT AG (LI) 2021-12-29 — — EP claimed
CN-106132380-B Photopolymerizable dual-cure dental materials based on thiourea derivatives 义获嘉伟瓦登特公司 2020-02-11 — — CN claimed
EP-2921156-B1 Monomer mixture for the preparation of dental materials IVOCLAR VIVADENT AG (LI) 2019-10-02 — — EP claimed
US-10195121-B2 Photopolymerizable and dual-curing dental materials based on thiourea derivatives IVOCLAR VIVADENT AG (LI) 2019-02-05 — — US claimed
US-10130562-B2 Monomer mixture for the preparation of dental materials IVOCLAR VIVADENT AG (LI) 2018-11-20 — — US claimed
US-20170143592-A1 MONOMER MIXTURE FOR THE PREPARATION OF DENTAL MATERIALS IVOCLAR VIVADENT AG (LI) 2017-05-25 — — US claimed
US-20170128328-A1 Photopolymerizable and dual-curing dental materials based on thiourea derivatives IVOCLAR VIVADENT AG (LI) 2017-05-11 — — US claimed
EP-2921154-B1 Photopolymerisable and dual hardening dental material based on thiourea derivatives and bisacyldialkylgermanium-compounds IVOCLAR VIVADENT AG (LI) 2017-03-08 — — EP claimed
EP-2921156-A1 Monomer mixture for the preparation of dental materials Ivoclar Vivadent AG (LI) 2015-09-23 — — EP claimed
EP-2921154-A1 Photopolymerisable and dual hardening dental material based on thiourea derivatives and bisacyldialkylgermanium-compounds Ivoclar Vivadent AG (LI) 2015-09-23 — — EP claimed
EP-4717249-A1 DENTAL COMPOSITION Shofu Inc. (JP) 2026-04-01 — — EP disclosed
US-20260083642-A1 DENTAL COMPOSITION SHOFU INC (JP) 2026-03-26 — — US disclosed
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE SHOFU INC (JP) 2026-03-26 — — US disclosed
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT SHOFU INC. (JP) 2026-03-05 — — US disclosed
US-20250381101-A1 HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION SHOFU INC. (JP) 2025-12-18 — — US disclosed
US-20100068679-A1 Dental materials with a high flexural modulus IVOCLAR VIVADENT AG (LI) 2010-03-18 — — US disclosed
EP-2163235-A1 Dental materials with high bending module Ivoclar Vivadent AG (LI) 2010-03-17 — — EP disclosed
EP-1974712-A1 Dental material based on radically polymerisable N,O-functionalised acrylic acid hydroxamides Ivoclar Vivadent AG (LI) 2008-10-01 — — EP disclosed
US-20080234405-A1 very quickly cured; particularly suitable for dental purposes IVOCLAR VIVADENT AG (LI) 2008-09-25 — — US disclosed
US-20080076847-A1 Polymerizable compositions with acylgermanes as initiatiors IVOCLAR VIVADENT AG (LI) 2008-03-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060900-A1 DENTAL COMPOSITE RESIN KIT BOLA2; BOLA2B, LBR, COL2A1 TDP1 1382/4885TSHR 3276/4885CYP3A4 4813/4885
US-20260083644-A1 METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE ARCN1, LBR, POLL TDP1 772/4885TSHR 3634/4885CYP3A4 2914/4885
US-20250381101-A1 HIGHLY FLOWABLE DENTAL CURABLE COMPOSITION RCC1, H1-0, H1-3 TDP1 2386/4885TSHR 2062/4885CYP3A4 3140/4885
US-20080076847-A1 Polymerizable compositions with acylgermanes as initiatiors NR1I3, NR4A1, NR1I2 TDP1 4575/4885TSHR 807/4885CYP3A4 151/4885
US-20080234405-A1 very quickly cured; particularly suitable for dental purposes HRH4, HRH2, HRH3 TDP1 4522/4885TSHR 3656/4885CYP3A4 324/4885
US-20260083642-A1 DENTAL COMPOSITION TAS2R42, COL2A1, TAS2R1 TDP1 2239/4885TSHR 1588/4885CYP3A4 4710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback